Delivery Order SPE2DB20D1100-SPE2DB25FD6G1
- Not listed
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for supply of Clobazam 10 mg tablets in a quantity of 100 units, valued at $1,555.93. The award, issued on August 12, 2025, carries a firm fixed price structure with an ultimate completion date of August 13, 2025. This is a non-set-aside competitive award, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. The place of performance is located...
- The Defense Logistics Agency awarded a delivery order valued at $7,435.86 to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Clobazam 10 mg tablets (100-count packages). This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 11, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The contract contains no set-aside designation, indicating it was competed among all eligible vendors. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Clobazam 10 mg tablets (100 count) with a ceiling value of $4,491.92. This is a firm fixed price delivery order with no set-aside designation, executed under competitive procedures. The order is scheduled for ultimate completion on August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Clobazam 10 mg tablets (100-count) with a ceiling value of $3,414.22. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's substantial pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Clobazam 10 mg tablets (100-count) valued at $1,555.93 under a firm fixed price contract. The award was made on July 30, 2025, with an ultimate completion date of July 31, 2025, and represents a non-competitive delivery against an existing contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location in the same city. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $7,222.21 to AmerisourceBergen Drug Corp for 100 tablets of Clobazam 10 mg, effective July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order represents a straightforward pharmaceutical procurement with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- This delivery order, awarded July 23, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, provides 100 tablets of Clobazam 10 mg at a ceiling value of $6,303.15. The contract is a firm fixed-price delivery order with an ultimate completion date of July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting the contractor's capability to...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Clobazam 10mg tablets in a quantity of 100 units, with a contract ceiling value of $3,111.86. This firm fixed-price delivery order represents a non-competitive set-aside award and is scheduled for completion by August 12, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Clobazam 10 mg tablets in a quantity of 100 units, with a ceiling value of $7,124.30. This firm fixed-price delivery order is scheduled for completion by August 12, 2025, with performance to be fulfilled at the contractor's Conshohocken, Pennsylvania facility. The award was made on a competitive, non-set-aside basis, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,667.79 to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Clobazam 10 mg tablets in quantities of 100. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD6G1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Clobazam 10 mg tablets in a quantity of 100 units, valued at $3,111.86. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The contract was awarded on July 24, 2025, with an ultimate completion date of July 25, 2025, and will be performed at the company's headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support for military healthcare programs, enabling the contractor to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities. The underlying IDC facilitates the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems' access to critical pharmaceutical products across multiple therapeutic domains on a flexible and responsive basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 7/24/25 |